The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

One-Year Clinical Outcomes of a Novel Transcatheter Heart Valve to treat Degenerated Surgical Valves - The “VIVALL” study

DOI: 10.4244/EIJ-D-20-01241

1. Marienhospital Hamburg, Hamburg, Germany, Germany
2. Heart Center Brandenburg in Bernau & Brandenburg Medical School, Bernau, Germany
3. Segeberger Clinics, Heart Center, Bad Segeberg, Germany
4. University of Cologne, Department of Cardiology, Cologne, Germany
5. Clinic and Policlinic Heart Surgery, University Clinic Bonn, Bonn, Germany
6. Heart Surgery Clinic, University Heart Center, Hamburg, Germany
Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention and external reviewers - has been published immediately upon acceptance as it was received in the last round of revision. The content of this article is the responsibility of the authors.

Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.

To read the full content of this article, please log in to download the PDF.

First in-human clinical studies and in-vitro tests for VIV with the ALLEGRA THV (NVT GmbH, Hechingen, Germany) as well as the 30-day data of the VIVALL study demonstrated favourable results, even in small surgical aortic bioprotheses1,2,3. This paper reports the 12-month outcomes of the VIVALL study.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
The new European Bifurcation Club consensus; long stenting using contemporary DES; five-year outcomes of CTO stenting; online three-dimensional OFDI-guided bifurcation PCIs; a mini focus on radial access in coronary interventions using ultrasound or prolonged occlusion flow-mediated dilatation; anaesthesia vs deep sedation in transcatheter mitral valve repair and more…